Walleye Capital LLC Relay Therapeutics, Inc. Transaction History
Walleye Capital LLC
- $46.2 Billion
- Q3 2024
A detailed history of Walleye Capital LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 1,819,983 shares of RLAY stock, worth $7.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,819,983
Previous 26,926
6659.2%
Holding current value
$7.9 Million
Previous $175,000
7262.86%
% of portfolio
0.03%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RLAY
# of Institutions
204Shares Held
156MCall Options Held
207KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$121 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$62.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$45.8 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$40.1 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$32 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $522M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...